Brian A. Leuthner, President and CEO at Edge Therapeutics, Inc. (EDGE), sold 1,500 shares at $9.52 ($14K) on 2017-02-07, disclosed to the SEC on 2017-02-08.
Scheduled sale ($14k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EDGE | SELL | 2018-02-23 | $77K | — | Filing → |
| EDGE | SELL | 2018-02-02 | $65K | — | Filing → |
| EDGE | SELL | 2018-01-03 | $51K | — | Filing → |